BioNTech Aktie
WKN DE: A2PSR2 / ISIN: US09075V1026
03.11.2021 15:15:12
|
CVS Pharmacy To Offer Pfizer-BioNTech's COVID-19 Pediatric Vaccine Starting On Sunday
(RTTNews) - CVS Health (CVS) said that certain CVS Pharmacy will offer a two-dose primary series of the Pfizer-BioNTech COVID-19 pediatric vaccine to children ages five to 11 years of age starting on Sunday.
It follows authorization of the vaccine by the Centers for Disease Control and Prevention (CDC) based on guidance from the organization's Advisory Committee on Immunization Practices and Food and Drug Administration (FDA) Emergency Use Authorization.
The vaccine will be available at nearly 1,700 CVS Pharmacy locations in 46 states, Puerto Rico and Washington D.C., the company said.
In a separate press release, Rite Aid said it is prepared to begin administering doses of Pfizer-BioNTech's COVID-19 pediatric vaccine to children aged 5-11 as soon as the 10 microgram doses are distributed to Rite Aid, which is expected at the end of this week.
The first available appointments for age 5-11 doses will be on Saturday, November 6. Those appointments may be booked through our scheduling tool beginning Thursday, November 4.
The Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age is administered as a two-dose primary series, 3 weeks apart, but is a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30 micrograms).

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
16:04 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte ein CVS Health-Investment von vor einem Jahr eingefahren (finanzen.at) | |
18.04.25 |
S&P 500-Titel CVS Health-Aktie: So viel hätten Anleger an einem CVS Health-Investment von vor 10 Jahren verloren (finanzen.at) | |
17.04.25 |
Börse New York: S&P 500 zum Start des Donnerstagshandels fester (finanzen.at) | |
16.04.25 |
Erste Schätzungen: CVS Health gewährt Anlegern Blick in die Bücher (finanzen.net) | |
11.04.25 |
S&P 500-Titel CVS Health-Aktie: So viel Gewinn hätte ein Investment in CVS Health von vor 5 Jahren eingefahren (finanzen.at) | |
08.04.25 |
Schwacher Wochentag in New York: S&P 500 fällt zum Handelsende zurück (finanzen.at) | |
08.04.25 |
Optimismus in New York: S&P 500 notiert im Plus (finanzen.at) | |
08.04.25 |
Dienstagshandel in New York: S&P 500-Anleger greifen am Dienstagmittag zu (finanzen.at) |
Analysen zu BioNTech (ADRs)mehr Analysen
26.03.25 | BioNTech Buy | Deutsche Bank AG | |
21.03.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.03.25 | BioNTech Buy | Goldman Sachs Group Inc. | |
14.03.25 | BioNTech Buy | Deutsche Bank AG | |
11.03.25 | BioNTech Buy | Goldman Sachs Group Inc. |
Aktien in diesem Artikel
BioNTech (ADRs) | 86,40 | -17,64% |
|
CVS Health Corp | 57,37 | -0,68% |
|
Rite Aid Corp Registered Shs | 0,70 | -74,26% |
|